SBC Medical Group Holdings Incorporated · NASDAQ:SBC
SBC Medical — Q3 2024 Earnings Presentation
12 slides from SBC Medical's earnings presentation, November 2024
Slide 1: 2024 Third Quarter Financial Highlights
2024 Third Quarter Financial Highlights November 2024
Slide 2: Disclaimer
Disclaimer This presentation contains certain financial measures that are not recognized under generally accepted accounting principles in the United States (“GAAP”), including EBITDA and EBITDA margin. For a reconciliation of these non-GAAP financial measures to the most directly comparable GAAP me
Slide 3: 3Q24 YTD Highlights: Growth Across the Board
3Q24 YTD Highlights: Growth Across the Board • Almost all key figures have experienced growth relative to 3Q23 YTD. SBC Medical Group Holdings Key Financials (24Q3 YTD) Franchise Clinics Key Figures Total revenues EBITDA*¹ EBITDA Margin*² Number of Franchise clinics ・Sep24 $160M $68M 42% 224clinics
Slide 4: Revenue Growth Driven by Diverse Services
Revenue Growth Driven by Diverse Services • Revenue has steadily increased in line with the expansion of number of clinics. • Management services decreased mainly by the stop of staffing services. +15.1 (mm US$) +9.6 +6.5 +2.8 +19.9 (9.2) 176.1 160.9 131.1 23Q3 Royalty Procurement Management Rental
Slide 5: EBITDA Growth Driven by Top Line
EBITDA*¹ Growth Driven by Top Line • EBITDA has also been steadily increased. • “Stock-based compensation expenses” is one time expense related to the listing process. (mm US$) +29.8 +6.4 +12.8 (1.5) (1.1) (4.3) +2.2 (12.8) 87.7 68.4 56.3 23Q3 YTD Revenue Cost of Salaries Consulting Stock-based Othe
Slide 6: Robust Balance Sheet Positioned for Growth
Robust Balance Sheet Positioned for Growth • SBC’s balance sheet is strong with ample cash and borrowing capacity. Key Balance Sheet Figures (as of September 30, 2024) Selected items from Balance Sheet Dec 31, June 30, Sep 30, (mm US$) 2023 2024 2024 QoQ Total assets 258 255 296 +41 Total current as
Slide 7: Public Shareholder Driven Capital Policy
Public Shareholder Driven Capital Policy • Shareholder return, growth investment, and building a strong capital base are all important considerations to ensure value creation reflecting our commitment to public shareholders. Shareholder Return • Maximizing SBC’s shareholder value with robust busines
Slide 8: Appendix
Medical Group Holdings, Inc. Appendix S B co Medical G rOuD Holdings, Inc.
Slide 9: Income Statement (Consolidated)
Income Statement (Consolidated) Income Statement Operating Expenses FY23 23Q3 24Q3 23Q3 24Q3 23Q3 24Q3 (mm US$) YTD YTD YTD % YoY % YoY YTD YTD % YoY (mm US$) Total revenues 193 131 160 +23% 47 53 +12% Total operating expenses 47 56 +20% Royalty income 42 25 45 +79% 8 15 +82% Salaries and welfare 20
Slide 10: Balance Sheet (Consolidated)
Balance Sheet (Consolidated) Dec 31, June 30, Sep 30, Dec 31, June 30, Sep 30, (mm US$) 2023 2024 2024 QoQ 2023 2024 2024 QoQ (mm US$) Total assets 258 255 296 +41 Total liabilities 114 94 90 (3) Total current assets 165 169 202 +32 Total current liabilities 92 75 72 (2) Cash and cash equivalent 103
Slide 11: Cash Flows (Consolidated)
Cash Flows (Consolidated) FY23 23Q3 24Q3 YTD YTD YTD % YoY (mm US$) Net cash provided by operating activities 50 22 27 +23% Net cash provided by (used in) investing activities 1 8 (5) (164)% Net cash provided by financing activities 6 6 11 +85% Effect of changes in foreign currency exchange rate (7)
Slide 12: Reconciliation Table on Non-GAAP Financials
Reconciliation Table on Non-GAAP Financials 23Q3 24Q3 23Q3 24Q3 (mm US$) YTD YTD (A) Total Revenues 131 160 47 53 (B) Income from operations 46 65 20 13 Depreciation and amortization (C) expense 9 2 3 1 (D) =(B)+(C) EBITDA 56 68 23 14 (E) =(D)／(A) EBITDA Margin 43% 42% 49% 28% 12
SBC Medical Group Holdings — Q3 2024 Earnings Presentation on 6ix